Search results for: Healthcare Systems

The Benefits of Early Engagement with Payers and Patient Representatives: The Case Study of a MoCA Pilot Project on ANCA-associated Vasculitis

30 June 2022

…early dialogue; to discuss unmet needs of the disease, and the value that a novel treatment could bring to patients and healthcare systems. As part of MoCA, the Transparent Value…

Pedro Pita Barros

30 August 2023

…Economics and his research career in health economics has a focus on healthcare systems, competition and economic regulation. His research has been widely disseminated in high-impact peer-reviewed journals and has…

SooChin Yen

28 November 2023

…in adherence to the policies and guidelines from Public Health England (PHE) and Joint Committee on Vaccination and Immunisation (JCVI). She is interested in bringing innovation to our healthcare systems…

Pedro Pita Barros

2 January 2025

…Economics and his research career in health economics has a focus on healthcare systems, competition and economic regulation. His research has been widely disseminated in high-impact peer-reviewed journals and has…

OHE’s Adrian Towse to Take Office as ISPOR President

3 June 2014

…require creating incentives in health care systems to achieve better outcomes, and creating the tools and systems to measure performance. In other words, diverse health systems have diverse needs for…

“You Don’t Always Get What You Want”: Output Distortion and NHS Waiting Time Targets

18 December 2018

…long been a concern in the English NHS where healthcare, free at the point of use, is rationed by waiting time. They have been regular fodder for the media and…

Looking Further Afield – What Can Health Economics Learn from the Environmental Economics Approach to Discounting?

1 February 2024

…is seen most clearly when costs and benefits occur at different points in time. In a healthcare context, this is most apparent when evaluating advanced therapy medicinal products (ATMPs), medicines…

2022 Innovation Policy Prize

…enforced; and (3) it must be “fair” as between countries, so that each makes an appropriate contribution to support the global investment in innovation. The current systems of pricing pharmaceuticals fail on all…

OHE at ISPOR’s 20th Annual European Congress in Glasgow

2 November 2017

…for orphan drugs sustainable for healthcare systems, whilst providing a ‘fair’ reward to manufacturers investing in areas of high unmet need but small populations. Martina will start the session providing…